Dayagdag, Esterlita R.
HRN: 16-37-49 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CEFTAZIDIME 1GM (VIAL)
11/03/2023
11/10/2023
IV
1gm
TID
CAP On Top Of PTB
Waiting Final Action